Results 31 to 40 of about 328 (258)

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Low complexity duty cycle modulation model predictive current control of permanent magnet synchronous motor

open access: yesIET Power Electronics, 2023
This study proposes a model predictive current control algorithm for the synchronous permanent magnet motor with low complexity duty cycle modulation. Three single‐phase voltage vectors are simulated to synthesize the target voltage vector that enables ...
Deliang Yu   +3 more
doaj   +1 more source

An FCS-MPC Strategy for Series APF Based on Deadbeat Direct Compensation

open access: yesEnergies, 2023
Aiming at the delay caused by the phase-locked loop (PLL) and harmonic detection in the traditional control of a series active power filter (SAPF), a deadbeat direct control (DBDC)-based finite control set model predictive control (FCS-MPC) strategy for ...
Guifeng Wang, Xujie Gao, Chunjie Li
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Robust predictive current control of permanent magnet synchronous motor using voltage coefficient matrix update

open access: yesInternational Journal of Electrical Power & Energy Systems
In this study, a novel robust deadbeat predictive current control algorithm using voltage coefficient matrix update (DPCC-VCMU) is proposed for permanent magnet synchronous motor (PMSM), which can eliminate the influence of model parameter mismatch ...
Jing He   +5 more
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Artificial Neural Network-Based Deadbeat Predictive Current Control with Dead-Time Compensation for PMSMs

open access: yesITEGAM-JETIA
  In the velocity control of Permanent Magnet Synchronous Motors (PMSMs), Deadbeat Predictive Current Controllers (DPCCs) are renowned for their excellent dynamic performance and constant switching frequency.
amira amira Slimani   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy